image credit: Adobe Stock

FDA clears first at-home flu and COVID test, days after its developer files for bankruptcy

February 27, 2023


Lucira was one of several diagnostic companies that rose to prominence during the pandemic. In November 2020, the California-based company received the first FDA authorization for a fully at-home COVID-19 test. Early the following year, Lucira raised $176 million through an initial public offering. As demand for COVID-19 tests waned in 2022, the company worked to get a flu combination test to market by the fall of last year.

Read More on Biopharma Dive